HLS Therapeutics Inc.
TSX:HLS.TO
3.37 (CAD) • At close November 13, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) CAD.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 63.074 | 61.467 | 60.009 | 56.109 | 54.16 | 61.415 | 75.082 | 54.031 | 19.956 | 73.877 | 79.466 | 116.556 | 78.746 | 88.099 | 71.876 | 68.147 | 100.589 | 49.661 | 68.202 | 77.809 | 83.214 | 35.52 | 33.25 | 99.832 | 95.627 | 101.319 | 76.24 | 59.653 |
Cost of Revenue
| 7.624 | 4.981 | 3.972 | 3.625 | 1.932 | 2.595 | 4.136 | -0.104 | -0.215 | 53.029 | 62.506 | 91.426 | 58.24 | 70.446 | 61.21 | 56.648 | 81.863 | 46.453 | 63.885 | 73.181 | 74.115 | 29.895 | 27.524 | 94.67 | 88.861 | 98.395 | 73.655 | 58.243 |
Gross Profit
| 55.45 | 56.486 | 56.037 | 52.484 | 52.228 | 58.82 | 70.946 | 54.135 | 20.171 | 20.848 | 16.96 | 25.13 | 20.506 | 17.653 | 10.666 | 11.499 | 18.726 | 3.208 | 4.317 | 4.628 | 9.099 | 5.625 | 5.727 | 5.162 | 6.766 | 2.925 | 2.586 | 1.41 |
Gross Profit Ratio
| 0.879 | 0.919 | 0.934 | 0.935 | 0.964 | 0.958 | 0.945 | 1.002 | 1.011 | 0.282 | 0.213 | 0.216 | 0.26 | 0.2 | 0.148 | 0.169 | 0.186 | 0.065 | 0.063 | 0.059 | 0.109 | 0.158 | 0.172 | 0.052 | 0.071 | 0.029 | 0.034 | 0.024 |
Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
General & Administrative Expenses
| 8.39 | 17.735 | 17.397 | 18.485 | 18.09 | 14.463 | 11.877 | 1.36 | 2.681 | 4.682 | 4.485 | 3.146 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Selling & Marketing Expenses
| 19.896 | 17.846 | 14.66 | 12.9 | 6.256 | 4.323 | 3.551 | 3.201 | 2.538 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
SG&A
| 28.286 | 35.581 | 32.057 | 31.385 | 24.346 | 18.786 | 15.428 | 1.36 | 2.681 | 4.682 | 4.485 | 3.146 | 3.853 | 0 | 0 | 0 | 0 | 0 | 0.021 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Expenses
| 37.513 | 34.402 | 30.264 | 33.186 | 32.51 | 32.395 | 32.233 | 0.003 | 0.03 | -0.018 | 0 | 0 | 0.281 | 12.444 | 6.607 | 0.11 | -0.114 | 1.043 | 10.703 | 3.658 | 3.864 | 2.129 | 2.228 | 2.569 | 2.831 | 1.56 | 0.629 | 0.371 |
Operating Expenses
| 65.799 | 69.983 | 62.321 | 64.571 | 56.856 | 51.181 | 47.661 | 1.36 | 2.681 | 4.682 | 4.485 | 3.146 | 4.134 | 12.444 | 6.607 | 4.216 | 6.732 | 1.818 | 2.478 | 3.658 | 3.864 | 2.129 | 2.228 | 2.569 | 2.831 | 1.56 | 0.629 | 0.371 |
Operating Income
| -10.349 | -13.44 | -6.24 | -11.256 | -4.043 | 7.639 | 23.285 | -1.256 | -2.466 | 16.166 | 12.476 | 21.984 | 16.458 | 17.653 | 4.059 | 4.447 | 12.069 | 1.35 | -0.144 | 0.969 | 5.235 | 3.496 | 3.499 | 2.592 | 3.936 | 1.365 | 1.957 | 1.039 |
Operating Income Ratio
| -0.164 | -0.219 | -0.104 | -0.201 | -0.075 | 0.124 | 0.31 | -0.023 | -0.124 | 0.219 | 0.157 | 0.189 | 0.209 | 0.2 | 0.056 | 0.065 | 0.12 | 0.027 | -0.002 | 0.012 | 0.063 | 0.098 | 0.105 | 0.026 | 0.041 | 0.013 | 0.026 | 0.017 |
Total Other Income Expenses Net
| -17.454 | -10.225 | -5.524 | -4.212 | -15.835 | -36.442 | -24.43 | -27.939 | -2.533 | 0.825 | 0.347 | 0.591 | -0.04 | -10.54 | -0.776 | -8.409 | -1.135 | 0.396 | 10.352 | -10.315 | -0.542 | 0.796 | 0.787 | -0.042 | 0.053 | -7.149 | 0.769 | -0.223 |
Income Before Tax
| -27.803 | -23.722 | -11.808 | -16.299 | -20.463 | -28.803 | -1.145 | -1.039 | -2.217 | 16.992 | 12.822 | 22.575 | 16.418 | 1.666 | 3.282 | -3.962 | 10.934 | 1.747 | 10.208 | -8.531 | 4.692 | 4.291 | 4.286 | 2.55 | 5.662 | -5.849 | 2.655 | 0.816 |
Income Before Tax Ratio
| -0.441 | -0.386 | -0.197 | -0.29 | -0.378 | -0.469 | -0.015 | -0.019 | -0.111 | 0.23 | 0.161 | 0.194 | 0.208 | 0.019 | 0.046 | -0.058 | 0.109 | 0.035 | 0.15 | -0.11 | 0.056 | 0.121 | 0.129 | 0.026 | 0.059 | -0.058 | 0.035 | 0.014 |
Income Tax Expense
| -0.272 | -0.124 | 1.309 | -0.968 | -0.911 | -3.997 | 4.952 | -0.164 | -0.485 | 4.274 | 3.09 | 5.708 | 4.088 | 2.4 | 0.729 | 1.679 | 3.339 | 0.437 | 0.701 | 0.157 | 1.804 | 1.344 | 1.377 | 1.146 | 1.105 | 0.78 | 0.908 | -0.445 |
Net Income
| -27.531 | -23.598 | -13.117 | -15.331 | -19.552 | -24.806 | -6.097 | -0.875 | -1.732 | 12.717 | 9.733 | 16.867 | 11.983 | -0.734 | 2.554 | -5.641 | 7.595 | 1.31 | 9.507 | -8.689 | 2.888 | 2.947 | 2.909 | 2.288 | 4.074 | -6.629 | 1.747 | 6.9 |
Net Income Ratio
| -0.436 | -0.384 | -0.219 | -0.273 | -0.361 | -0.404 | -0.081 | -0.016 | -0.087 | 0.172 | 0.122 | 0.145 | 0.152 | -0.008 | 0.036 | -0.083 | 0.076 | 0.026 | 0.139 | -0.112 | 0.035 | 0.083 | 0.087 | 0.023 | 0.043 | -0.065 | 0.023 | 0.116 |
EPS
| -0.85 | -0.73 | -0.41 | -0.48 | -0.67 | -0.92 | -0.24 | -0.035 | -0.098 | 0.65 | 0.49 | 0.83 | 0.6 | -0.032 | 0.11 | -0.22 | 0.33 | 0.06 | 0.46 | -0.46 | 0.15 | 0.13 | 0.18 | 0.21 | 0.39 | -0.69 | 0.23 | 1.03 |
EPS Diluted
| -0.85 | -0.73 | -0.41 | -0.48 | -0.67 | -0.92 | -0.24 | -0.035 | -0.098 | 0.65 | 0.49 | 0.82 | 0.6 | -0.032 | 0.11 | -0.22 | 0.33 | 0.06 | 0.46 | -0.46 | 0.15 | 0.13 | 0.18 | 0.21 | 0.37 | -0.69 | 0.23 | 1.03 |
EBITDA
| 12.884 | 17.997 | 25.412 | 23.194 | 19.746 | 20.702 | 55.518 | 38.242 | -2.466 | 20.014 | 18.464 | 29.193 | 22.292 | 14.105 | 11.006 | 8.663 | 18.726 | 3.208 | 4.297 | 4.628 | 9.099 | 5.625 | 5.727 | 5.162 | 6.766 | 2.925 | 2.516 | 1.41 |
EBITDA Ratio
| 0.204 | 0.341 | 0.4 | 0.391 | 0.526 | 0.349 | 0.741 | -0.023 | -0.124 | 0.265 | 0.235 | 0.25 | 0.283 | 0.131 | 0.153 | 0.127 | 0.185 | 0.065 | 0.092 | 0.059 | 0.109 | 0.158 | 0.172 | 0.052 | 0.071 | 0.029 | 0.034 | 0.024 |